首页 | 本学科首页   官方微博 | 高级检索  
检索        

5种终末期肝病模型判断原发性肝癌患者预后的比较
引用本文:文洁,朱德增.5种终末期肝病模型判断原发性肝癌患者预后的比较[J].兰州医学院学报,2010(4):68-72.
作者姓名:文洁  朱德增
作者单位:第二军医大学附属长海医院中医科,上海200433
摘    要:目的评价终末期肝病模型(MELD)及其联合血清钠相关模型判断原发性肝癌(PHC)患者预后的能力,包括终末期肝病血清钠模型(MELD-Na)、终末期肝病血清钠腹水模型(MELD-AS)、终末期肝病血清钠年龄模型(iMELD)和终末期肝病血清钠值比模型(MESO)。方法回顾性分析300例PHC患者资料。采用受试者工作特征曲线及曲线下面积(AUC)评价5种模型判断患者预后的能力;不同患者生存率的差异采用Kaplan-Meier方法的Log-rank检验进行计算。结果判断患者3、12个月的预后,MELD-AS的AUC最大(0.793和0.639),与其余各模型的AUC差异均有统计学意义;MELD、MELD-Na、MELD-AS、iMELD、MESO的最佳截值点分别为5.0、5.0、6.0、21.0和0.4,以此截值点对患者进行分组,各模型高低分值组间患者的生存率均有显著性差异(P〈0.001)。结论 5种终末期肝病模型均可作为判断原发性肝癌患者预后的指标,以MELD-AS判断患者中短期预后能力最佳。

关 键 词:肝肿瘤  预后模型  终末期肝病模型

Comparison of five models for end-stage liver disease to predict the prognosis of patients with primary hepatic cancer
WEN Jie,ZHU De-zeng.Comparison of five models for end-stage liver disease to predict the prognosis of patients with primary hepatic cancer[J].Journal of Lanzhou Medical College,2010(4):68-72.
Authors:WEN Jie  ZHU De-zeng
Institution:(Department of Traditional Chinese Medicine,Changhai Hospital,Second Military Medical University, Shanghai,200433,China)
Abstract:Objective To investigate the prognostic accuracy of the model for end-stage liver disease(MELD) and four new MELD-based models combination with serum sodium in primary hepatic cancer(PHC) patients-the MELD with the incorporation of serum sodium(MELD-Na), incorporating MELD,persistent ascites and low serum sodium(MELD-AS),the integrated MELD including serum sodium and age(iMELD),and the MELD to sodium index(MESO).Methods A total of 300 patients with PHC were enrolled into the study.MELD,MELD-Na,MELD-AS, iMELD and MESO scores were calculated for each patient following the original formula on the first day of admission.All patients were followed up at least 1 year.The predictive prognosis related with the five models was determined by the area under the receiver operating characteristic curve(AUC).Kaplan-Meier survival curves were made using the cut-offs identified by means of receiver operating characteristic(ROC).Results The MELD-AS had the highest AUC(0.793) 3 months after the enrollment,and was followed by the MELD(0.742),MELD-Na(0.741),iMELD (0.729) and MESO(0.727).The difference between the MELD-AS score and each of the other MELD scores was statistically significant(all P0.04);12 month after enrollment,the MELD-AS had the highest AUC(0.639),and was followed by the iMELD(0.615),MELD-Na(0.613),MELD (0.608) and MESO(0.604).The difference between the MELD-AS score and each of the other MELD scores was statistically significant except for iMELD(P=0.357).The most discriminative cut-offs from the ROC with the z-statistic for MELD,MELD-Na,MELD-AS,iMELD and MESO were 5.0,5.0,6.0,21.0 and 0.4 at 3 month of enrollment.Survival curves showed that the MELD and four new MELD-based models were all clearly discriminated the patients who survived or died in short-term as well as intermediate-term(P0.001) according to these cut-offs.Conclusion MELD and four new MELD-based models,changed with serum sodium(MELD-Na,MELDAS, iMELD and MESO),can exactly predict the prognosis of patients with PHC in short and intermediate period.The MELD-AS may be the best prognostic model for outcome prediction in patients with PHC of the five MELD-based models.
Keywords:liver neoplasms  prognostic model  model for end-stage liver disease
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号